David McCracken, MD
Neurological Surgery · Atlanta, GANPI 1881983492
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $364,579 of the $425,296 with a category attached, or 85.7%. GT Medical Technologies, Inc accounts for 87.5% of it on its own, with 23 other manufacturers making up the rest. 2025 is the largest year on record at $154,335, more than ten times the $2,073 reported in 2019. Among neurological surgery clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 294 payments — averaging $1446.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GT Medical Technologies, Inc$372K
- Stryker$41K
- NX Development Corp.$10K
- Medtronic$1K
- Novocure Inc.$290
- Brainlab, Inc.$91
- plus $785 from 18 others
What the payments were for
- Consulting fees$364,57986%
- Speaking & faculty fees$18,6114%
- Travel & lodging$30,8807%
- Food & beverage$11,2273%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GT Medical Technologies, Inc | 207 | $372,055 |
| Stryker | 36 | $41,033 |
| NX Development Corp. | 3 | $9,717 |
| Medtronic | 11 | $1,326 |
| Novocure Inc. | 4 | $290 |
| Brainlab, Inc. | 4 | $91 |
| Longeviti Neuro Solutions Inc | 1 | $90 |
| Johnson & Johnson | 3 | $88 |
| Integra Lifesciences Corporation | 3 | $78 |
| Novartis | 3 | $72 |
| AstraZeneca(2 entities) | 3 | $67 |
| Arbor Pharmaceuticals, Inc. | 3 | $61 |
| Olympus America Inc. | 1 | $51 |
| Medexus Pharma, Inc. | 1 | $50 |
| Spineology Inc. | 1 | $42 |
| Zimmer Biomet | 2 | $29 |
| Coherus Oncology, Inc. | 1 | $28 |
| Globus Medical | 1 | $26 |
| Bayer | 1 | $24 |
| Neurelis, Inc. | 1 | $23 |
| Sunovion Pharmaceuticals Inc. | 1 | $21 |
| Irras USA, Inc. | 1 | $16 |
| Kyowa Kirin, Inc. | 1 | $12 |
| Omniscient Neurotechnology America Ltd | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GammaTile$370,276
- SPETZLER-MALIS$13,900
- Gleolan$9,663
- CORE$9,203
- UNIVERSAL NEURO 3$5,940
- MAKO$4,400
- ADHERUS AUTOSPRAY ET DURAL SEALANT$2,650
- ADHERUS AUTOSPRAY DURAL SEALANT$2,650
- SONOPET IQ$1,400
- DIRECT INJECT$1,400
- CUSTOM IMPLANTS$1,019
- VISUALASE$950
- DURAMATRIX$550
- Optune$233
- NEURO$198
- NSE - ROUTERS$170
- NA$132
- N/A$115
How this compares
$425,296 in reported general payments places this provider in the 95th percentile of 201 neurological surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levetiracetam | 18 | $239 |
| Dexamethasone | 16 | $233 |
| Oxycodone Hcl | 53 | $221 |
| Famotidine | 17 | $75 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Atlanta
- Regis HaidAtlanta$25.5M
- Thomas MorrisonAtlanta$2.8M
- Christopher TomarasAtlanta$1.5M
- Daniel RefaiAtlanta$1.2M
- Gerald RodtsAtlanta$1.2M
- James RobinsonAtlanta$993K
- Michele JohnsonAtlanta$540K
- Robert GrossAtlanta$315K
- Kaveh KhajaviAtlanta$225K
- Joshua WewelAtlanta$114K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.